Biomedicine and Biotechnology
ISSN (Print): 2378-5527 ISSN (Online): 2378-5535 Website: http://www.sciepub.com/journal/bb Editor-in-chief: Apply for this position
Open Access
Journal Browser
Go
Biomedicine and Biotechnology. 2014, 2(1), 1-9
DOI: 10.12691/bb-2-1-1
Open AccessReview Article

Mechanism of DNA Binding and Cleavage

Sangeetha Gowda K.R.1, Blessy Baby Mathew2, C.N. Sudhamani1 and H.S. Bhojya Naik1,

1Department of Studies and Research in Industrial Chemistry, School of Chemical Sciences, Kuvempu University, Shankaraghatta, India

2Department of Biotechnology, Sapthagiri College of Engineering, Bangalore, India

Pub. Date: December 26, 2013

Cite this paper:
Sangeetha Gowda K.R., Blessy Baby Mathew, C.N. Sudhamani and H.S. Bhojya Naik. Mechanism of DNA Binding and Cleavage. Biomedicine and Biotechnology. 2014; 2(1):1-9. doi: 10.12691/bb-2-1-1

Abstract

The necessity for cellular regulation of DNA led to the development of metallonucleases to catalyze and repair DNA strand breaks. Due to cationic character, three-dimensional structural profiles, and propensity for performing hydrolysis, redox, or photoreactions of metal ions and complexes, have a natural ability for interacting with DNA. Since binding and cleavage of DNA is at the heart of cellular transcription and translation, it is an obvious target for therapeutic intervention and the development of diagnostic structural probes. Inorganic constructs such as cisplatin and its analogs exercise antitumor activity by inner-sphere coordination to DNA. During the last decades, the continuous evolution of artificial metallonucleases and metal-based chemotherapeutics such as cisplatin, photo-active octahedral metal complexes have been successfully used as DNA luminescent probes and light-driven reactive agents during the last decades. A recent emerging trend to improve their potential as molecular tools for studies of the genetic material is the design of bifunctional assemblies where the photo-active metal centre is tethered through a flexible linker to a nucleic acid recognition or reactive moiety. In this view, new metal complexes have been designed that utilize or create open coordination positions for DNA binding and hydrolysis, generate reactive oxygen containing species or other radicals for DNA oxidation, or perform direct redox reactions with DNA. This review briefly covers the aspects of drug molecule interaction factors, modes of DNA binding via groove binders, intercalators and alkylators along with the cleavage patterns such as hydrolytic, oxidative and photoinduced DNA cleavage, taking an example of Cisplatin and its mechanism.

Keywords:
DNA DNA binding DNA cleavage DNA drug interaction

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 8

References:

[1]  Shaikh, S.A., Jayaram, B., “DNA Drug Interaction”, Department of Chemistry and Supercomputing Facility for Bioinformatics and Computational Biology, Indian Institute of Technology.
 
[2]  Gajendragad, M. R., Agarwala, U., Anorg, Z., “1, 3, 4-Thiadiazole-2, 5-dithiol as a Complexing Agent II. Complexes of NiII, RhI, PdII, PtII, AuIII, and CuII”, Allg. Chem., 415, 84, 1975.
 
[3]  Ronconi,L., Sadler,P.J., “Using coordination chemistry to design new medicines”, Coord. Chem. Rev., 251, 1633, 2007.
 
[4]  Kennard, O., Pure & App. Chem, Cambridge Crystallographic Data Centre, Vol 65, pp 6. , 1993.
 
[5]  Yunus,G., Sreevatsava,S., Gupta, V.D.,A theoretical analysis of drug-DNA interactions: stability of poly D (at) binding with aminosteroid dipyrandium”, Department of Physics, Integral University.
 
[6]  Beaudoin, A.R., “Teratogenic activity of 2-amino-1,3,4-thiadiazole hydrochloride in Wistar rats and the protection afforded by nicotinamide”, Teratology, 7, 65-71, 1973.
 
[7]  Looker, J.H., Wilson Jr. L.W., “1, 2, 3-Thiadiazoles as potential antineoplastic agents I. Synthesis of novel 4-monosubstituted and 4,5-disubstituted derivatives”, J. Heterocyclic. Chem., 2, 348, 1965.
 
[8]  Clerici,F., Pocar,D., Brufani,M., “Synthesis of 2-Amino-5-sulfanyl-1,3,4-thiadiazole Derivatives and Evaluation of Their Antidepressant and Anxiolytic Activity”, J. Med. Chem., 44, 931, 2001.
 
[9]  Gowda, K.R.S., Naik, H.S.B., Kumar, B.V., Sudhamani, C.N., Sudeep, H.V., Naik, T.R.R., Krishnamurthy, G. “Synthesis, antimicrobial, DNA-binding and photonuclease studies of Cobalt(III) and Nickel(II) Schiff base complexes”, Spectrochimica Acta Part A, 105: 229-237, 2013.
 
[10]  Arjmand,F., Muddassir,M., “A mechanistic approach for the DNA binding of chiral enantiomeric L- and D-tryptophan-derived metal complexes of 1,2-DACH: Cleavage and antitumor activity”, Chirality, 23, 250, 2011.
 
[11]  Liu,J., Zou, X.H., Zhang, Q.L., Mei, W.J., Liu, J.Z., Ji, L.N., “Synthesis, Characterization and Antitumor Activity of a Series of Polypyridyl Complexes”, Met. Based Drugs, 7 343, 2000.
 
[12]  Pindur, U., Haber, M., Sattler, K., “Antitumor active drugs as intercalators of deoxyribonucleic acid: Molecular models of intercalation complexes“, J. Chem. Educ., 70, 263, 1993.
 
[13]  Sudhamani, C.N., Naik, H.S.B., Girija, D., Gowda, K.R.S., Giridhar, M., Arvinda, T., “Novel complexes of Co(III) and Ni(II) containing peptide ligands:Synthesis, DNA binding and photonuclease activity“, Spectrochimica Acta Part A, 2014; 118: 271-278.
 
[14]  Sabine, H., Rijt, V., Sadler, P.J., “Current application and future potential for bio inorganic chemistry in the development of anti cancer drug”, University of Warwich, Vol 14, pp: 23-24, 2009.
 
[15]  Mizyed, S., Kiwan, R., Marji, D., “Synthesis of New Azacrown Ether Schiff-Bases and their Complexes with C60”, Jordan Journal of Chemistry, 8, 71-78, 2013.
 
[16]  Dhar, S., Nethaji, M., Chakravarty, R.A., “Synthesis, crystal structure and photo-induced DNA cleavage activity of ternary copper(II) complexes of NSO-donor Schiff bases and NN-donor heterocyclic ligands”, Inorganica Chimica Acta, 358 (7). pp. 2437-2444, 2005.
 
[17]  Leung-Toung, R., Wodzinska, J., Li, W., Lowrie, J., Kukreja, R., Desilets, D., Karimian, K., Tam, T. F., ”1,2,4-thiadiazole: a novel Cathepsin B inhibitor”, Bioorg. Med. Chem. Lett., 11, 5529, 2003.
 
[18]  Matysiak, J., Skrzypek, A., Feewiadomy, A., ” Synthesis and antifungal activity of novel 5-substituted 4-(1,3,4-thiadiazol-2-yl)benzene-1,3-diols” , Heteroatom Chem., 21, 533, 2010.
 
[19]  Palchaudhuri, R., Hergenrother, P.J., “DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action”, Current Opinion in Biotechnology, Volume 18, Issue 6, Pages 497-503, 2007.
 
[20]  Mei, H., Barton, J., "A Chiral Probe for A-form Helices of DNA and RNA: Tris(tetramethylphenanthroline)ruthenium(II)", J. Am. Chem. Soc., 108, 7414, 1986.
 
[21]  Raman, N., Selvan, A., “Investigation of DNA binding mechanism, photoinduced cleavage activity, electrochemical properties and biological functions of mixed ligand copper(II) complexes with benzimidazole derivatives: synthesis and spectral characterization”, Journal of Enzyme Inhibition and Medicinal Chemistry, 27, 380-389.
 
[22]  Brown, T., Brown (Jr), T., Nucleic Acids Book, ATDBIO.
 
[23]  Wu, L., “Unveiling biomacromolecule interactions- NMR and optical spectroscopy studies on ligand binding to DNA and lysozyme”, Chalmers University of Technology, Gothenburg, Sweden, 2013.
 
[24]  Sinha, R., Islam, M.M., Kakali, B., Gopinatha, S.K., Banerjee, A., Maiti, M., “The binding of DNA intercalating and non-intercalating compounds to A-form and protonated form of poly(rC)-poly(rG): Spectroscopic and viscometric study”, Bioorg. & Medic. Chem., 14: 800-814, 2006.
 
[25]  Fukui, K., Tanaka, K., “The Acridine Ring Selectively Intercalated into a DNA Helix at Various Types of Abasic Sites: Double Strand Formation and Photophysical Properties”, Nucleic Acids Res., 24: 3962-3967, 1996.
 
[26]  Salson-Behmoaras, T., Tocque, B., Rey, I., Casslgnol, M., Thuong, N-T., Helene, C. “Short modified antisense oligonucleotides directed against Ha-ras point mutation induce selective cleavage of the mRNA and inhibit T24 cells proliferation”, EMBO J., 10: 1111-1118, 1991.
 
[27]  Moucheron, C. Kirsch-De Mesmaeker, “New DNA-binding ruthenium(II) complexes as photo-reagents for mononucleotides and DNA C.”, J. Physical Organic Chemistry, 11, 577-583, 1998.
 
[28]  Denny, W.A.,"DNA minor groove alkylating agents." Current medicinal chemistry, 8, 533-544, 2001.
 
[29]  Wang, J.C., “Cellular roles of DNA topoisomerases: a molecular perspective”, Nat. Rev. Mol. Cell. Biol., 3, 430-440, 2002.
 
[30]  Bickle, T.A., Krüger, D.H.,“Biology of DNA restriction”, Microbiol. Rev., 57, 434-450, 1993.
 
[31]  Samejima, K., Earnshaw, W.C., “Trashing the genome: the role of nucleases during apoptosis”, Nat. Rev. Mol. Cell. Biol., 6, 677-688, 2005.
 
[32]  Chen, J., Stubbe, J., “Bleomycins: towards better therapeutics”, Nat. Rev. Cancer, 5, 102 112, 2005.
 
[33]  Hengartner, M.O., “The biochemistry of apoptosis”, Nature, 407, 770-776, 2000.
 
[34]  Kochetkov, N.K., Budovskii, E.I, Reactions Involving the Cleavage or Rearrangement of Heterocyclic Rings of Nucleic Acid Bases and their Derivatives. Organic Chemistry of Nucleic Acids, Springer, 1972, pp 381-423.
 
[35]  Kochevar, I. E.; Dunn, A., “Photosensitized reactions of DNA: cleavage and addition”, Bioorg. Photochem., 1, 273, 1990.
 
[36]  Paillous, N; Vicendo, P. J., “Mechanisms of photosensitized DNA cleavage”, Photochem. Photobiol. B, 20, 203, 1993.
 
[37]  Fernandez, M.J., Grant, K. B., Herraiz, F.,Yang, X., Lorente, A, “DNA photocleavage by dicationic bisintercalants”, Tetrahedron Lett., 2001, 42, 5701-04.
 
[38]  Armitag B., “Photocleavage of Nucleic Acids”, Chem. Rev., 98, 1171, 1998.
 
[39]  B. Meunier, G. Pratviel, J. Bernadou, “Active Species Involved in Oxidative DNA Cleavage”, Bull. Soc. Chim. Fr., 131, 933-943, 1994.
 
[40]  Sawyer, D.T., Valentine, J.S., “How super is superoxide? ” , Acc. Chem. Res., 14, 393-400, 1981.
 
[41]  Piette, J., “Biological consequences associated with DNA oxidation mediated by singlet oxygen”, J. Photochem. Photobiol. B, 11, 241-260, 1991.
 
[42]  Epe, B., “Genotoxicity of singlet oxygen”, Chem. Biol. Interact., 80(3), 239-260, 1991.
 
[43]  Sigman, D.S., Mazumder, A., Perrin, D.M., “Chemical nucleases”, Chem. Rev., 93, 2295-2316, 1993.
 
[44]  Armitage, B., “ Photocleavage of nucleic acids”, Chemical reviews, 98(3), 1171-1200, 1998.
 
[45]  Kobayashi, T., Tobita, S., Kobayashi, M., Imajyo, T., Chikira, M., Yashiro, M., & Fujii, Y., “Effects of N-alkyl and ammonium groups on the hydrolytic cleavage of DNA with a Cu(II)TACH (1,3,5-triaminocyclohexane) complex. Speciation, kinetic, and DNA-binding studies for reaction mechanism”, J Inorg Biochem., 101, 348-361, 2007.
 
[46]  Jin, Y., Cowan, J. A., “DNA cleavage by copper-ATCUN complexes. Factors influencing cleavage mechanism and linearization of dsDNA”, J Am Chem Soc., 8408-8415, June 2005.
 
[47]  Ren, R., Yang, P., Zheng, W., & Hua, Z., “A Simple Copper(II)−L-Histidine System for Efficient Hydrolytic Cleavage of DNA”, Inorganic chemistry, 39, 5454-5463, 2000.
 
[48]  Reddy, P. R., Manjula, P., “Ternary complexes of cobalt cysteinylglycine with histidylserine and histidylphenylalanine–stabilities and DNA cleavage properties” J. Chem. Sci., 119, 603-612 November 2007.
 
[49]  Park, H. J., Kwon, J. H., Wang, W., Lee, H. G., Kim, C., Kim, Y., & Cho, T. S.,“Oxidative DNA Cleavage by Zn(X-BDPA)(NO3)2 Complexes (X=F, H, and Me): Effect of Different Ligand Substituents”, Bull. Korean Chem. Soc., 33, 1819, 2012.
 
[50]  Maheswari, P. U., Lappalainen, K., Sfregola, M., Barends, S., Gamez, P., Turpeinen, U., Reedijk, J., “Structure and DNA cleavage properties of two copper(II) complexes of the pyridine-pyrazole-containing ligands mbpzbpy and Hmpzbpya”, Dalton Trans., 3676-3683, 2007.
 
[51]  Zhao, Y., Zhu, J., He, W., Yang, Z., Zhu, Y., Li, Y., Guo, Z, “Oxidative DNA cleavage promoted by multinuclear copper complexes: activity dependence on the complex structure”, Chemistry., 25, 6621 August 2006.
 
[52]  Allison, R. R., Downie, G. H., Cuenca, R., Hu, X. H., Childs, C. J., & Sibata, C. H., “Photosensitizers in clinical PDT”, Photodiagnosis and Photodynamic Therapy 1, 27-42, 2004.
 
[53]  Wang, D., Lippar, S.J., “Cellular processing of platinum anticancer drugs”, Nature Reviews Drug Discovery 4, 307-320, April 2005.